1,599
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Precise engineering of cetuximab encapsulated gadollium nanoassemblies: in vitro ultrasound diagnosis and in vivo thyroid cancer therapy

, , , &
Pages 569-579 | Received 11 Jan 2021, Accepted 09 Feb 2021, Published online: 12 Mar 2021

References

  • Balaji S, Mohamed Subarkhan MK, Ramesh R, et al. (2020). Synthesis and structure of arene Ru(II) N∧O-chelating complexes: in vitro cytotoxicity and cancer cell death mechanism. Organometallics 39:1366–75.
  • Balbín A, Gaballo F, Ceballos-Torres J, et al. (2014). Dual application of Pd nanoparticles supported on mesoporous silica SBA-15 and MSU-2: supported catalysts for C–C coupling reactions and cytotoxic agents against human cancer cell lines. RSC Adv 4:54775–87.
  • Cutignano A, Seetharamsingh B, D'Angelo D, et al. (2017). Identification and synthesis of mycalol analogues with improved potency against anaplastic thyroid carcinoma cell lines. J Nat Prod 80:1125–33.
  • García-Fernández L, Garcia-Pardo J, Tort O, et al. (2017). Conserved effects and altered trafficking of Cetuximab antibodies conjugated to gold nanoparticles with precise control of their number and orientation. Nanoscale 9:6111–21.
  • Heskamp S, Boerman OC, Molkenboer-Kuenen JDM, et al. (2014). Cetuximab reduces the accumulation of radiolabeled bevacizumab in cancer xenografts without decreasing VEGF expression. Mol Pharm 11:4249–57.
  • Ho YJ, Wu CH, Jin Q, et al. (2020). Superhydrophobic drug-loaded mesoporous silica nanoparticles capped with β-cyclodextrin for ultrasound image-guided combined antivascular and chemo-sonodynamic therapy. Biomaterials 232:119723..
  • Hu Y, Dong XZ, Liu X, et al. (2016). Enhanced antitumor activity of cetuximab in combination with the jak inhibitor CYT387 against non-small-cell lung cancer with various genotypes. Mol Pharm 13:689–97.
  • Iwashina T, Mochida J, Miyazaki T, et al. (2006). Low-intensity pulsed ultrasound stimulates cell proliferation and proteoglycan production in rabbit intervertebral disc cells cultured in alginate. Biomaterials 27:354–61..
  • Kabeer FA, Rajalekshmi DS, Nair MS, Prathapan R. (2019). In vitro and in vivo antitumor activity of deoxyelephantopin from a potential medicinal plant Elephantopus scaber against Ehrlich ascites carcinoma. Biocatal Agric Biotechnol 19:101106..
  • Kamiya K, Takeuchi S. (2017). Giant liposome formation toward the synthesis of well-defined artificial cells. J Mater Chem B 5:5911–23.
  • Kang Y, Kim J, Park J, et al. (2019). Tumor vasodilation by N-Heterocyclic carbene-based nitric oxide delivery triggered by high-intensity focused ultrasound and enhanced drug homing to tumor sites for anti-cancer therapy. Biomaterials 217:119297..
  • Kim DH, Kim DK, Zhou K, et al. (2017). Single particle tracking-based reaction progress kinetic analysis reveals a series of molecular mechanisms of cetuximab-induced EGFR processes in a single living cell. Chem Sci 8:4823–32.
  • Kim H, Goh SH, Choi Y. (2021). Quenched cetuximab conjugate for fast fluorescence imaging of EGFR-positive lung cancers. Biomater Sci 9:456–62.
  • Kim J, Song J, Ji HD, et al. (2019). Discovery of potent, selective, and orally bioavailable estrogen-related receptor-γ inverse agonists to restore the sodium iodide symporter function in anaplastic thyroid cancer. J Med Chem 62:1837–58.
  • Kim J, Woo SY, Im CY, et al. (2016). Insights of a lead optimization study and biological evaluation of novel 4-hydroxytamoxifen analogs as estrogen-related receptor γ (ERRγ) inverse agonists. J Med Chem 59:10209–27.
  • Kong X, Pan P, Sun H, et al. (2019). Drug discovery targeting anaplastic lymphoma kinase (ALK). J Med Chem 62:10927–54.
  • Lee L, Robb LM, Lee M, et al. (2010). Design, synthesis, and biological evaluations of 2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoline analogs of combretastatin-A4. J Med Chem 53:325–34.
  • Liu J, Xu F, Huang J, et al. (2018). Low-intensity focused ultrasound (LIFU)-activated nanodroplets as a theranostic agent for noninvasive cancer molecular imaging and drug delivery. Biomater Sci 6:2838–49.
  • Mohamed Kasim MS, Sundar S, Rengan R. (2018). Synthesis and structure of new binuclear ruthenium(ii) arene benzil bis(benzoylhydrazone) complexes: investigation on antiproliferative activity and apoptosis induction. Inorg Chem Front 5:585–96.
  • Mohamed Subarkhan MK, Ramesh R, Liu Y. (2016). Synthesis and molecular structure of arene ruthenium(II) benzhydrazone complexes: Impact of substitution at the chelating ligand and arene moiety on antiproliferative activity. New J Chem 40:9813–23.
  • Mohamed Subarkhan MK, Ren L, Xie B, et al. (2019). Novel tetranuclear ruthenium(II) arene complexes showing potent cytotoxic and antimetastatic activity as well as low toxicity in vivo. Eur J Med Chem 179:246–56.
  • Mohan N, Mohamed Subarkhan MK, Ramesh R. (2018). Synthesis, antiproliferative activity and apoptosis-promoting effects of arene ruthenium(II) complexes with N, O chelating ligands. J Organomet Chem 859:124–31.
  • Nabi-Meibodi M, Vatanara A, Najafabadi AR, et al. (2013). The effective encapsulation of a hydrophobic lipid-insoluble drug in solid lipid nanoparticles using a modified double emulsion solvent evaporation method. Colloids Surf B Biointerfaces 112:408–14..
  • Nair BP, Sharma CP. (2012). Poly(lactide-co-glycolide)-laponite-F68 nanocomposite vesicles through a single-step double-emulsion method for the controlled release of doxorubicin. Langmuir 28:4559–64.
  • Naso L, Valcarcel M, Villacé P, et al. (2014). Specific antitumor activities of natural and oxovanadium(iv) complexed flavonoids in human breast cancer cells. New J Chem 38:2414–21.
  • Pan J, Zhang L, Xu S, et al. (2018). Induction of apoptosis in human papillary-thyroid-carcinoma BCPAP cells by diallyl trisulfide through activation of the MAPK signaling pathway. J Agric Food Chem 66:5871–8.
  • Paolino D, Cosco D, Licciardi M, et al. (2008). Polyaspartylhydrazide copolymer-based supramolecular vesicular aggregates as delivery devices for anticancer drugs. Biomacromolecules 9:1117–30.
  • Parker JP, Ude Z, Marmion CJ. (2016). Exploiting developments in nanotechnology for the preferential delivery of platinum-based anti-cancer agents to tumours: targeting some of the hallmarks of cancer. Metallomics 8:43–60.
  • Sathiya Kamatchi T, Mohamed Subarkhan MK, Ramesh R, et al. (2020). Investigation into antiproliferative activity and apoptosis mechanism of new arene Ru(ii) carbazole-based hydrazone complexes. Dalton Trans 49:11385–95.
  • Subarkhan MKM, Ramesh R. (2016). Ruthenium(II) arene complexes containing benzhydrazone ligands: Synthesis, structure and antiproliferative activity. Inorg Chem Front 3:1245–55.
  • Sung FL, Pang RTK, Ma BBY, et al. (2006). Pharmacoproteomics study of cetuximab in nasopharyngeal carcinoma. J Proteome Res 5:3260–7.
  • Suriano R, Lin Y, Ashok BT, et al. (2006). Pilot study using SELDI-TOF-MS based proteomic profile for the identification of diagnostic biomarkers of thyroid proliferative diseases. J Proteome Res 5:856–61.
  • Tokranova NA, Novak SW, Castracane J, Levitsky IA. (2013). Deep infiltration of emissive polymers into mesoporous silicon microcavities: nanoscale confinement and advanced vapor sensing. J Phys Chem C 117:22667–76.
  • Wang M, Yang Q, Li M, et al. (2020). Multifunctional nanoparticles for multimodal imaging-guided low-intensity focused ultrasound/immunosynergistic retinoblastoma therapy. ACS Appl Mater Interfaces 12:5642–57.
  • Wang WC, Shiao HY, Lee CC, et al. (2014). Anaplastic lymphoma kinase (ALK) inhibitors: a review of design and discovery. MedChemComm 5:1266–79.
  • Wang Y, Zhang J, Lv X, et al. (2020). Mitoxantrone as photothermal agents for ultrasound/fluorescence imaging-guided chemo-phototherapy enhanced by intratumoral H2O2-Induced CO. Biomaterials 252:120111.
  • Yalcin TE, Ilbasmis-Tamer S, Takka S. (2020). Antitumor activity of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNs): in vitro and in vivo. Int J Pharm 580:119246..
  • Yang A, Qiao B, Strohm EM, et al. (2020). Thrombin-responsive engineered nanoexcavator with full-thickness infiltration capability for pharmaceutical-free deep venous thrombosis theranostics. Biomater Sci 8:4545–58.
  • Zeng D, Guo Y, White AG, et al. (2014). Comparison of conjugation strategies of cross-bridged macrocyclic chelators with cetuximab for copper-64 radiolabeling and PET imaging of EGFR in colorectal tumor-bearing mice. Mol Pharm 11:3980–7.
  • Zhang WH, Chen S, Liu XL, et al. (2020). Study on antitumor activities of the chrysin-chromene-spirooxindole on Lewis lung carcinoma C57BL/6 mice in vivo. Bioorganic & Medicinal Chemistry Letters 30:127410..
  • Zheng J, Cheng X, Xu S, et al. (2019). Diallyl trisulfide induces G2/M cell-cycle arrest and apoptosis in anaplastic thyroid carcinoma 8505C cells. Food Funct 10:7253–61.
  • Zhong Y, Zhang Y, Xu J, et al. (2019). Low-intensity focused ultrasound-responsive phase-transitional nanoparticles for thrombolysis without vascular damage: a synergistic nonpharmaceutical strategy. ACS Nano 13:3387–403.
  • Zhou M, Chen Y, Adachi M, et al. (2015). Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer. Biomaterials 57:41–9..
  • Zhou Q, Zeng Y, Xiong Q, et al. (2019). Construction of CNA35 collagen-targeted phase-changeable nanoagents for low-intensity focused ultrasound-triggered ultrasound molecular imaging of myocardial fibrosis in rabbits. ACS Appl Mater Interfaces 11:23006–17.
  • Zhu L, Zhao H, Zhou Z, et al. (2018). Peptide-functionalized phase-transformation nanoparticles for low intensity focused ultrasound-assisted tumor imaging and therapy. Nano Lett 18:1831–41.